Braden Parker
Corporate Officer/Principal at ORCHARD THERAPEUTICS PLC
Braden Parker active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ORCHARD THERAPEUTICS PLC | Corporate Officer/Principal | - | - |
Career history of Braden Parker
Former positions of Braden Parker
| Companies | Position | Start | End |
|---|---|---|---|
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Training of Braden Parker
| The Leonard N Stern School of Business | Masters Business Admin |
| University of Notre Dame | Undergraduate Degree |
Statistics
International
| United States | 4 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PTC THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Braden Parker
- Experience
